| Literature DB >> 32301979 |
Odaro J Huckstep1,2, Holger Burchert1, Wilby Williamson1, Fernando Telles1, Cheryl M J Tan1, Mariane Bertagnolli1,3, Linda Arnold1, Afifah Mohamed1,4, Kenny McCormick5, Henner Hanssen6, Paul Leeson1, Adam J Lewandowski1.
Abstract
AIMS: We tested the hypothesis that the known reduction in myocardial functional reserve in preterm-born young adults is an independent predictor of exercise capacity (peak VO2) and heart rate recovery (HRR). METHODS ANDEntities:
Keywords: cardiac reserve; echocardiography; exercise capacity; heart rate recovery; prematurity; preterm birth
Mesh:
Year: 2021 PMID: 32301979 PMCID: PMC8081423 DOI: 10.1093/ehjci/jeaa060
Source DB: PubMed Journal: Eur Heart J Cardiovasc Imaging ISSN: 2047-2404 Impact factor: 6.875
Cohort clinical characteristics
| Group characteristics | Preterm-born young adults ( | Term-born young adults ( |
|
|---|---|---|---|
| Demographics and anthropometrics | |||
| Age (years) | 22.7 ± 3.04 | 23.6 ± 3.8 | 0.239 |
| Gestational age (weeks) | 32.8 ± 3.23 | 39.5 ± 1.37 |
|
| 32–36 weeks, | 38 (80.9) | 0 (0.0) | |
| 28–31 weeks, | 5 (10.6) | 0 (0.0) | |
| <28 weeks, | 4 (8.5) | 0 (0.0) | |
| Male, | 14 (30) | 26 (48) | 0.061 |
| Birth weight (grams) | 1916 ± 806 | 3390 ± 424 |
|
| Gestational hypertension, | 8 (17.0) | 0 (0.0) |
|
| Small for gestational age, | 2 (4.3) | 0 (0.0) | 0.214 |
| Height (cm) | 167 ± 9 | 175 ± 10 |
|
| BMI (kg/m2) | 23.3 ± 4.5 | 22.7 ± 2.7 | 0.401 |
| Biochemistry | |||
| Total cholesterol (mmol/L) | 4.72 ± 0.65 | 4.18 ± 0.77 |
|
| HDL (mmol/L) | 1.49 ± 0.31 | 1.47 ± 0.26 | 0.882 |
| LDL (mmol/L) | 2.80 ± 0.71 | 2.32 ± 0.60 |
|
| Triglycerides (mmol/L) | 1.12 ± 0.66 | 0.87 ± 0.36 |
|
| High sensitivity CRP (mg/L) | 1.57 ± 2.42 | 1.14 ± 1.96 | 0.412 |
| Glucose (mmol/L) | 5.02 ± 0.41 | 4.82 ± 0.51 |
|
| Insulin (pmol/L) | 51.1 ± 29.0 | 35.8 ± 29.4 |
|
| Insulin resistance | 0.96 ± 0.54 | 0.68 ± 0.59 |
|
| Brachial blood pressure (mmHg) | |||
| Resting systolic | 119 ± 9 | 115 ± 8 |
|
| Resting diastolic | 70 ± 8 | 66 ± 5 |
|
| Average 24h systolic | 119 ± 6 | 119 ± 8 | 0.385 |
| Average 24h diastolic | 71 ± 5 | 69 ± 5 | 0.065 |
| Cardiac function | |||
| Heart rate (b.p.m.) | 75 ± 13 | 61 ± 12 |
|
| Ejection fraction (%) | 63.1 ± 5.4 | 63.4 ± 4.7 | 0.624 |
| Stroke index (mL/m2) | 29.6 ± 6.4 | 32.2 ± 7.8 | 0.173 |
| Pulmonary function | |||
| FVC (% of predicted) | 109 ± 15.2 | 109 ± 12.0 | 0.917 |
| FEV1/FVC (%) | 81.4 ± 6.4 | 81.6 ± 8.1 | 0.795 |
Group characteristics presented as mean ± SD. Biochemistry, blood pressure, cardiac function, and pulmonary function P-values adjusted for sex. Insulin resistance was calculated using the Homeostatic Model Assessment Index (HOMA) calculator (www.dtu.ox.ac.uk/homacalculator/). Bold P values are statistically significant (P<0.05).
BMI, body mass index; FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; HDL, high density lipoprotein; LDL, low-density lipoprotein.
Exercise characteristics
| Preterm-born young adults ( | Term-born young adults ( |
| |
|---|---|---|---|
| Exercise performance | |||
| Per cent of predicted peak VO2 | 94 ± 20 | 108 ± 25 |
|
| Peak VO2 (mL/kg/min) | 33.6 ± 8.6 | 40.1 ± 9.0 |
|
| OUE slope | 2.39 ± 0.73 | 3.05 ± 0.89 |
|
| VE/VCO2 slope | 28.1 ± 3.3 | 25.9 ± 3.8 |
|
| Peak RER | 1.19 ± 0.06 | 1.19 ± 0.06 | 0.738 |
| Cardiovascular function | |||
| Heart rate at VAT (b.p.m.) | 132 ± 18 | 124 ± 17 |
|
| Heart rate at 60% intensity (b.p.m.) | 159 ± 11 | 151 ± 14 | 0.055 |
| Peak HR achieved (b.p.m.) | 189 ± 9 | 186 ± 11 | 0.218 |
| HRR1 (b.p.m.) | −21 ± 9 | −24 ± 9 | 0.457 |
| HRR2 (b.p.m.) | −36 ± 13 | −43 ± 11 |
|
| Systolic blood pressure at 60% intensity (mmHg) | 146 ± 16 | 149 ± 14 | 0.567 |
| Diastolic blood pressure at 60% intensity (mmHg) | 81 ± 10 | 77 ± 7 | 0.139 |
| Peak systolic blood pressure (mmHg) | 165 ± 22 | 167 ± 21 | 0.885 |
| Peak diastolic blood pressure (mmHg) | 89 ± 11 | 82 ± 10 |
|
| Peak pulse pressure (mmHg) | 76 ± 23 | 86 ± 23 | 0.168 |
| Pulmonary function | |||
| Breaths per minute at peak VO2 | 44.3 ± 6.7 | 47.4 ± 11.8 | 0.188 |
| Ventilatory reserve at peak (%) | 23.3 ± 17.8 | 21.2 ± 18.3 | 0.513 |
| Objective measure of physical activity | |||
| MVPA (h/week) | 14.2 ± 5.8 | 14.9 ± 6.1 | 0.633 |
| VPA (h/week) | 0.9 ± 0.9 | 1.2 ± 1.2 | 0.146 |
Exercise characteristics presented as mean ± SD. P-values adjusted for sex. Bold P values are statistically significant (P<0.05).
HRR, heart rate recovery; MVPA, moderate to vigorous physical activity; OUE Slope, oxygen uptake efficiency slope; RER, respiratory exchange ratio; VAT, ventilatory anaerobic threshold; VE/VCO2, minute ventilation/carbon dioxide production;VO2, oxygen uptake; VPA, vigorous physical activity.
Multiple linear regression models of per cent of predicted peak VO2, HRR1, and HRR2 in preterm-born young adults
| Preterm-born young adults ( | ||||
|---|---|---|---|---|
| Per cent of predicted peak VO2 |
| 95%CI | Beta |
|
| Per cent of predicted FVC | 0.176 | −0.634 to 0.983 | 0.132 | 0.634 |
| Vent. reserve (%) | −0.234 | −0.883 to 0.415 | −0.205 | 0.435 |
| EFΔ40% (%) | 1.269 | −0.208 to 2.746 | 0.538 | 0.084 |
| Per cent of predicted peak VO2 | ||||
| Per cent of predicted FVC | 0.031 | −0.905 to 0.967 | 0.023 | 0.943 |
| Vent. reserve (%) | −0.270 | −0.886 to 0.345 | −0.236 | 0.354 |
| EFΔ60% (%) | 1.162 | −0.498 to 2.823 | 0.506 | 0.152 |
| HRR1 (b.p.m.) | ||||
| Per cent of predicted FVC | 0.227 | −0.106 to 0.561 | 0.367 | 0.159 |
| EFΔ60% (%) | −1.099 | −1.673 to −0.525 | −1.030 |
|
| HRR2 (b.p.m.) | ||||
| Per cent of predicted FVC | 0.170 | −0.293 to 0.633 | 0.198 | 0.432 |
| EFΔ60% (%) | −1.405 | −2.203 to −0.608 | −0.948 |
|
Bold P values are statistically significant (P<0.05). FVC represents forced vital capacity; EFΔ40%, ejection fraction change from rest to 40% exercise intensity; EFΔ60%, ejection fraction change from baseline to 60% exercise intensity; B, unstandardized regression coefficient.